13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 67 holding rows worth $4,739,611,392.
- Accession
- 0001493152-23-040729
- Filer
- CIK 1493215
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 67 entries on the cover page, a total value of $4,739,611,392 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,739,611,392 with VALUE read as dollars as filed, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 17,687,772 | $362,422,448 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 6,096,387 | $316,402,485 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 4,489,596 | $313,777,864 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,683,362 | $298,123,410 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 6,768,514 | $294,836,470 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 507,195 | $249,352,278 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 11,576,537 | $241,255,031 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 3,381,703 | $210,680,097 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 5,405,089 | $192,691,423 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 673,371 | $162,895,179 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 7,235,196 | $162,140,742 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 290,334 | $146,958,361 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 1,501,493 | $131,650,906 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 2,494,138 | $122,387,352 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 2,651,783 | $117,341,398 | dollars as filed | |
| VERICEL CORP | 92346J108 | COM | 3,291,873 | $110,343,583 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 5,149,482 | $105,976,340 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 3,463,201 | $95,307,292 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 5,415,514 | $90,330,774 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,574,198 | $75,835,873 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 7,136,415 | $73,505,075 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 1,519,956 | $62,698,185 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 16,893,185 | $53,382,465 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 2,880,701 | $51,190,057 | dollars as filed | |
| ORCHESTRA BIOMED HOLDINGS IN | 68572M106 | COMMON STOCK | 5,620,640 | $49,011,981 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,865,108 | $47,093,977 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 1,996,764 | $47,083,695 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 2,142,591 | $45,637,188 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 309,485 | $45,197,189 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 6,689,789 | $42,680,854 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 3,327,129 | $33,437,646 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 500,000 | $28,500,000 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 5,818,804 | $25,835,490 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 188,125 | $25,825,800 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 889,073 | $24,902,935 | dollars as filed | |
| AXONICS INC | 05465P101 | COM | 442,487 | $24,832,370 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 124,000 | $24,688,400 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 3,297,843 | $23,480,642 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,552,717 | $18,135,735 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 4,390,558 | $17,298,799 | dollars as filed | |
| NULL | 02008G102 | NULL | 3,457,707 | $14,868,140 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 500,887 | $14,846,291 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 2,375,785 | $14,587,320 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 857,464 | $12,013,071 | dollars as filed | |
| CUTERA INC | 232109108 | COM | 1,846,596 | $11,116,508 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 3,256,102 | $10,093,916 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 978,310 | $9,949,413 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 845,000 | $9,785,100 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 808,658 | $8,798,199 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 922,100 | $8,769,171 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 28,000 | $7,651,560 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 2,131,835 | $6,395,505 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 4,335,255 | $6,372,825 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,512,986 | $5,930,647 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 4,241,472 | $5,810,817 | dollars as filed | |
| APYX MEDICAL CORPORATION | 03837C106 | COM | 1,777,194 | $5,687,021 | dollars as filed | |
| DERMTECH INC | 24984K105 | COM | 2,718,356 | $3,914,433 | dollars as filed | |
| EXAGEN INC | 30068X103 | COM | 1,492,432 | $3,611,685 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 400,277 | $3,522,438 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 259,400 | $2,871,558 | dollars as filed | |
| OLINK HLDG AB | 680710100 | ADR | 163,652 | $2,413,867 | dollars as filed | |
| AKOYA BIOSCIENCES INC COM | 00974H104 | Stock | 338,422 | $1,573,662 | dollars as filed | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 127,970 | $1,384,635 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 46,300 | $1,027,860 | dollars as filed | |
| SIENTRA INC | 82621J204 | COMMON | 304,036 | $845,220 | dollars as filed | |
| MIROMATRIX MED INC | 60471P108 | COM | 445,222 | $583,241 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 350,000 | $59,500 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-23-040729 | this filing | 2023-11-14 | acceptance time not in the bulk data set |